Driven to Improve Outcomes
By Serving Providers
Brain cancer is a complex and deadly disease; treatment decisions rely on interpreting multiple, often subtle, tumor characteristics and changes on MRIs throughout the care process. Furthermore, contouring target volumes for radiation treatment and surgical planning is a time-consuming and variable process.
Neosoma has created a best-in-class tumor analysis and decision-support software platform based on rigorous science, driven by our mission to improve patient outcomes by delivering novel and necessary insights to the entire multidisciplinary team.

Filter Team:

Ken Kolodziej
Co-Founder and Chief Executive Officer

Charlotte Anderson
Controller

Amith Kamath, PhD
Radiation Oncology Engineering

Jona Hattangadi-Gluth, MD
Medical Advisor

Nicklaus Khan, MD
Medical Advisor

Akshitkumar Mistry, MD
Medical Advisor

Michael Hill
Chief Technology Officer

Josh Hess
Front-End Engineer

Katherine Kacena, PhD
Biostatistics

Rupesh Kotecha, MD
Medical Advisor

Richard Stark
Strategic Advisor

John Liedtky
Clinical Commercialization

David Mellenberg, PhD
Clinical Commercialization

Mauricio Reyes, PhD
AI Development

Robert Louis, MD
Medical Advisor

Adrianna Masters, MD
Medical Advisor

Michael Müller
Senior AI Engineer

Paul Meskell, PhD
Clinical Commercialization

Benjamin Ellingson, PhD
Scientific Advisor: R&D

Ashley Ghiaseddin, MD
Medical Advisor

Karan Dixit, MD
Medical Advisor
